» Articles » PMID: 16543363

Sixteen Years of HIV Surveillance in a West African Research Clinic Reveals Divergent Epidemic Trends of HIV-1 and HIV-2

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2006 Mar 18
PMID 16543363
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The HIV-1 epidemic in West Africa is characterized by a slower rise than that in Eastern and Southern Africa. The HIV-2 epidemic in West Africa may be declining, but few long-term data exist.

Methods: In a research clinic in The Gambia, HIV-1 and HIV-2 prevalence trends among all new patients being tested for HIV were examined over a 16 year period (1988 till 2003). In newly diagnosed patients a baseline CD4 count was done.

Results: An HIV test was done in 23 363 patients aged 15 years or older. The prevalence of HIV-1 was 4.2% in 1988-91 and rose to 17.5% in 2001-03 (P < 0.0001, chi(2)-test for trend). The prevalence of HIV-2 was 7.0% in 1988-91 and declined to 4.0% in 2001-03 (P < 0.0001). HIV-1 prevalence increased and HIV-2 prevalence decreased with time in logistic regression models adjusting for age, sex, and indication for test (P < 0.0001). Baseline CD4 counts were available for 65% of patients. The median CD4 count was 215 cells/mm3 [interquartile range (IQR) 72-424] for HIV-1, and 274 (IQR 100-549) for HIV-2 infected patients. There was no marked trend of rise or decline in baseline CD4 count in either HIV-1 or HIV-2 infected patients over the study period. Forty-five per cent of newly diagnosed HIV patients had a CD4 count <200 cells/mm3.

Conclusions: These data suggest that HIV-1 prevalence is rising in The Gambia, and that HIV-2 is declining. HIV patients in The Gambia present late and almost half of patients would qualify for anti-retroviral treatment at their first visit.

Citing Articles

Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans.

Tebit D, Nickel G, Gibson R, Rodriguez M, Hathaway N, Bain K EBioMedicine. 2024; 100:104965.

PMID: 38215691 PMC: 10827413. DOI: 10.1016/j.ebiom.2023.104965.


Molecular Biology and Diversification of Human Retroviruses.

Meissner M, Talledge N, Mansky L Front Virol. 2022; 2.

PMID: 35783361 PMC: 9242851. DOI: 10.3389/fviro.2022.872599.


The impact of maternal HIV and malaria infection on the prevalence of congenital cytomegalovirus infection in Western Kenya.

Otieno N, Nyawanda B, Otiato F, Oneko M, Amin M, Otieno M J Clin Virol. 2019; 120:33-37.

PMID: 31546088 PMC: 6815230. DOI: 10.1016/j.jcv.2019.09.007.


HIV-2 as a model to identify a functional HIV cure.

Esbjornsson J, Jansson M, Jespersen S, Mansson F, Honge B, Lindman J AIDS Res Ther. 2019; 16(1):24.

PMID: 31484562 PMC: 6727498. DOI: 10.1186/s12981-019-0239-x.


Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Samri A, Charpentier C, Diallo M, Bertine M, Even S, Morin V PLoS Pathog. 2019; 15(5):e1007758.

PMID: 31095640 PMC: 6541300. DOI: 10.1371/journal.ppat.1007758.